ClinConnect ClinConnect Logo
Search / Trial NCT06162637

Femoral Neck Locking Plate Vs Multiple Cannulated Cancellous Screws in Treatment of Femoral Neck Fractures in Young Adults: Randomized Controlled Clinical Trial Study

Launched by ESLAM MOHAMED AHMED · Dec 7, 2023

Trial Information

Current as of June 26, 2025

Not yet recruiting

Keywords

ClinConnect Summary

This clinical trial is comparing two different surgical methods for treating femoral neck fractures in young adults, which are breaks in the top part of the thigh bone near the hip joint. The trial will specifically look at the effectiveness of a locking plate versus multiple screws in helping these fractures heal properly. Femoral neck fractures can happen due to high-energy accidents, and it's important to treat them right away to avoid complications like poor blood supply to the hip, which can lead to further problems.

To be eligible for this trial, participants should be between 20 and 55 years old and have a single traumatic femoral neck fracture. They should have been able to walk independently before the injury. Unfortunately, individuals with certain conditions, like open fractures or other injuries in the same area, cannot participate. If you join this study, you will receive one of the two surgical treatments and be monitored for your recovery. This research aims to find out which method works better for young adults with these types of fractures.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • patients (20-55) years
  • having unilateral traumatic femoral neck fracture
  • idependent walker before trauma without any aids
  • Exclusion Criteria:
  • open fracture
  • pathological fracture
  • preexisting deformity
  • other pelvic or ipsilateral femoral injuries
  • renal impairment or were on high dose steroids

About Eslam Mohamed Ahmed

Eslam Mohamed Ahmed is a dedicated clinical trial sponsor committed to advancing medical research and improving patient outcomes. With a robust background in clinical methodologies and regulatory compliance, Eslam leads innovative studies aimed at evaluating the safety and efficacy of novel therapeutic interventions. His expertise encompasses various therapeutic areas, ensuring a thorough understanding of both the scientific and ethical dimensions of clinical research. Eslam's collaborative approach fosters strong partnerships with research institutions, healthcare professionals, and regulatory bodies, driving the successful execution of trials that contribute to the advancement of healthcare solutions.

Locations

Sohag, , Egypt

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported